ea0044p155 | Neuroendocrinology and pituitary | SFEBES2016
Cope Rosanne M A
, Powlson Andrew S
, Case Sarah J
, Koulouri Olympia
, Gurnell Mark
Background and aims: We have previously reported an increased prevalence of gallbladder polyps in treatment-naive acromegaly when compared with the general population (29 vs 4.6%), with potential implications for future malignant transformation and screening. However, little is known about biochemical markers of liver function in active acromegaly, or in response to treatment. Furthermore, somatostatin analogue (SSA) therapy is associated with the development of gallstones. He...